Proton pump inhibitors and nitric oxide mechanisms in type 2 diabetes.
Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Av. Bandeirantes, 3900, 14049-900, Ribeirao Preto, SP, Brazil, jonascau@gmail.com.
Jonas T C
JT
Sertorio
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D064098:Esomeprazole / Q000627:therapeutic use*; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
D007328:Insulin; D054328:Proton Pump Inhibitors; D064098:Esomeprazole